Last $123.52 USD
Change Today +3.35 / 2.79%
Volume 1.5M
As of 5:20 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey M. Leiden M.D., Ph.D.

Chairman, Chief Executive Officer and President, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 137 board members in 6 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Jeffrey M. Leiden, M.D., Ph.D., has been the Chief Executive Officer and President of Vertex Pharmaceuticals Incorporated since February 1, 2012. Dr. Leiden serves as a Senior Advisor at Clarus Ventures, LLC. He has more than 20 years of experience in the biomedical and pharmaceutical sectors. He served as Managing Director of Clarus Ventures since 2007, which he joined in 2006. He joined Clarus Ventures in November 1, 2006 as a Partner. He served as the President ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Member of Executive Committee of Board of Trustees
Former Chairman
Former Chairman
Former President of Pharmaceutical Products Group, Chief Operating Officer of Pharmaceutical Products Group and Director
Former Independent Director and Member of Research & Development Committee
Former Vice Chairman, Chairman of Science & Technology Committee, Member of Nomination Committee and Member of Remuneration Committee
Former Chairman, Member of Audit Committee and Member of Compensation Committee
Chairman, Chief Executive Officer and President
Director and Member of Compensation Committee


The University of Chicago
The University of Chicago
The University of Chicago
Harvard University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,038,462

Stock Options*

Restricted Stock Awards$1,773,963
All Other Compensation$12,675
Exercisable Options379,799
Exercisable Options Value$14,592,694
Unexercisable Options553,836
Unexercisable Options Value$16,423,130
Total Value of Options$31,015,824
Total Number of Options933,635

Total Compensation*

Total Annual Cash Compensation$3,823,137
Total Short Term Compensation$1,038,462
Other Long Term Compensation$1,786,638
Total Calculated Compensation$13,126,474
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $123.52 USD +3.35


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at